55 related articles for article (PubMed ID: 15015967)
1. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.
Nakamaki T; Kawabata H; Saito B; Matsunawa M; Suzuki J; Adachi D; Tomoyasu S; Phillip Koeffler H
Br J Haematol; 2004 Apr; 125(1):42-9. PubMed ID: 15015967
[TBL] [Abstract][Full Text] [Related]
2. Maternal iron status during pregnancy compared with neonatal iron status better predicts placental iron transporter expression in humans.
Best CM; Pressman EK; Cao C; Cooper E; Guillet R; Yost OL; Galati J; Kent TR; O'Brien KO
FASEB J; 2016 Oct; 30(10):3541-3550. PubMed ID: 27402672
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of ferritin subunits and iron transport proteins: an effect of targeted hepatic X-irradiation.
Naz N; Ahmad S; Cameron S; Moriconi F; Rave-Fränk M; Christiansen H; Hess CF; Ramadori G; Malik IA
Biomed Res Int; 2013; 2013():353106. PubMed ID: 24693535
[TBL] [Abstract][Full Text] [Related]
4. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.
Jabara HH; Boyden SE; Chou J; Ramesh N; Massaad MJ; Benson H; Bainter W; Fraulino D; Rahimov F; Sieff C; Liu ZJ; Alshemmari SH; Al-Ramadi BK; Al-Dhekri H; Arnaout R; Abu-Shukair M; Vatsayan A; Silver E; Ahuja S; Davies EG; Sola-Visner M; Ohsumi TK; Andrews NC; Notarangelo LD; Fleming MD; Al-Herz W; Kunkel LM; Geha RS
Nat Genet; 2016 Jan; 48(1):74-8. PubMed ID: 26642240
[TBL] [Abstract][Full Text] [Related]
5. A Novel Homozygous Germline Mutation in Transferrin Receptor 1 (TfR1) Leads to Combined Immunodeficiency and Provides New Insights into Iron-Immunity Axis.
Aba Ü; Maslak İC; İpşir C; Pehlivan D; Warnock NI; Tumes DJ; Cildir G; Erman B
J Clin Immunol; 2024 Jan; 44(2):55. PubMed ID: 38270687
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Resistance to Ionizing Radiation Exposure Is Accompanied by Decreased Cathepsin D and Increased Transferrin Receptor 1 Expression.
Pinto AT; Machado AB; Osório H; Pinto ML; Vitorino R; Justino G; Santa C; Castro F; Cruz T; Rodrigues C; Lima J; Sousa JLR; Cardoso AP; Figueira R; Monteiro A; Marques M; Manadas B; Pauwels J; Gevaert K; Mareel M; Rocha S; Duarte T; Oliveira MJ
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612268
[TBL] [Abstract][Full Text] [Related]
7. Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice.
An W; Feola M; Levy M; Aluri S; Ruiz-Martinez M; Sridharan A; Fibach E; Zhu X; Verma A; Ginzburg Y
Elife; 2023 Dec; 12():. PubMed ID: 38153418
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies.
Zhang H; Sun C; Sun Q; Li Y; Zhou C; Sun C
Front Mol Biosci; 2023; 10():1275774. PubMed ID: 37818101
[TBL] [Abstract][Full Text] [Related]
9. Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study.
Jin T; Ge L; Chen J; Wang W; Zhang L; Ge M
PeerJ; 2023; 11():e15592. PubMed ID: 37361050
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Weber S; Parmon A; Kurrle N; Schnütgen F; Serve H
Front Immunol; 2020; 11():627662. PubMed ID: 33679722
[TBL] [Abstract][Full Text] [Related]
11. Transferrin Receptors in Erythropoiesis.
Richard C; Verdier F
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352721
[TBL] [Abstract][Full Text] [Related]
12. Iron: An Essential Element of Cancer Metabolism.
Hsu MY; Mina E; Roetto A; Porporato PE
Cells; 2020 Dec; 9(12):. PubMed ID: 33287315
[TBL] [Abstract][Full Text] [Related]
13. From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells.
Grignano E; Birsen R; Chapuis N; Bouscary D
Front Oncol; 2020; 10():586530. PubMed ID: 33042852
[TBL] [Abstract][Full Text] [Related]
14. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology.
Brown RAM; Richardson KL; Kabir TD; Trinder D; Ganss R; Leedman PJ
Front Oncol; 2020; 10():476. PubMed ID: 32328462
[TBL] [Abstract][Full Text] [Related]
15. Iron and leukemia: new insights for future treatments.
Wang F; Lv H; Zhao B; Zhou L; Wang S; Luo J; Liu J; Shang P
J Exp Clin Cancer Res; 2019 Sep; 38(1):406. PubMed ID: 31519186
[TBL] [Abstract][Full Text] [Related]
16. The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value.
Roetto A; Mezzanotte M; Pellegrino RM
Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30360575
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression.
Sharp PA; Clarkson R; Hussain A; Weeks RJ; Morison IM
PLoS One; 2018; 13(5):e0197863. PubMed ID: 29771984
[TBL] [Abstract][Full Text] [Related]
18. Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients.
Greene CJ; Attwood K; Sharma NJ; Gross KW; Smith GJ; Xu B; Kauffman EC
Oncotarget; 2017 Dec; 8(63):107052-107075. PubMed ID: 29291011
[TBL] [Abstract][Full Text] [Related]
19. The relationship between systemic iron homeostasis and erythropoiesis.
Rishi G; Subramaniam VN
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29097483
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
